The HEV Ventilator

Autor: Buytaert, J., Abud, A. Abed, Allport, P., Álvarez, A. Pazos, Akiba, K., Francisco, O. Augusto de Aguiar, Bay, A., Bernard, F., Baron, S., Bertella, C., Brunner, J., Bowcock, T., Jode, M. Buytaert-De, Byczynski, W., De Carvalho, R., Coco, V., Collins, P., Collins, R., Dikic, N., Dousse, N., Dowd, B., Dumps, R., Durante, P., Fadel, W., Farry, S., Prieto, A. Fernández, Flynn, G., Lima, V. Franco, Frei, R., Torreira, A. Gallas, Guida, R., Hennessy, K., Henriques, A., Hutchcroft, D., Ilic, S., Jevtic, A., Joram, C., Kapusniak, K., Cid, E. Lemos, Lindner, J., Lindner, R., Milovanovic, M., Mico, S., Morant, J., Morel, M., Männe, G., Murray, D., Nasteva, I., Neufeld, N., Neuhold, I., López, F. Pardo-Sobrino, Trigo, E. Pérez, Jallas, G. Pichel, Pilorz, E., Piquilloud, L., Pons, X., Reiner, D., Roosens, C., Rostalski, P., Schmidt, B., Saucet, E., Sanders, F., Sigaud, C., Schoettker, P., Schwemmer, R., Schindler, H., Sharma, A., Svihra, P., van Leemput, J., Vignaux, L., Vasey, F., Woonton, H., Wyllie, K.

HEV is a low-cost, versatile, high-quality ventilator, which has been designed in response to the COVID-19 pandemic. The ventilator is intended to be used both in and out of hospital intensive care units, and for both invasive and non-invasive ventil

Externí odkaz: http://arxiv.org/abs/2007.12012

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease.

Autor: Lessard S; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA. samuel.lessard@sanofi.com.; Precision Medicine and Computational Biology, Sanofi, Cambridge, MA, 02141, USA. samuel.lessard@sanofi.com., Rimmelé P; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Ling H; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Moran K; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Vieira B; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Lin YD; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Rajani GM; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Hong V; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Reik A; Sangamo Therapeutics, Richmond, CA, 94804, USA., Boismenu R; Sangamo Therapeutics, Richmond, CA, 94804, USA., Hsu B; Sangamo Therapeutics, Richmond, CA, 94804, USA., Chen M; Sangamo Therapeutics, Richmond, CA, 94804, USA., Cockroft BM; Sangamo Therapeutics, Richmond, CA, 94804, USA., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes/National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, National Institutes of Health (NIH), Bethesda, MD, USA., Tisdale J; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes/National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, National Institutes of Health (NIH), Bethesda, MD, USA., Alavi A; Henry Ford Cancer Institute, Detroit, MI, USA., Krishnamurti L; Emory University, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Abedi M; University of California-Davis Medical Center, Sacramento, CA, USA., Galeon I; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Reiner D; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Wang L; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Ramezi A; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Rendo P; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Walters MC; University of California San Francisco Benioff Children's Hospital, Oakland, CA, USA., Levasseur D; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Peters R; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Harris T; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Hicks A; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA.; Immunology and Inflammation, Sanofi, Cambridge, MA, 02141, USA.

Publikováno v: Scientific reports [Sci Rep] 2024 Oct 16; Vol. 14 (1), pp. 24298. Date of Electronic Publication: 2024 Oct 16.

Democracy, economic development and low carbon energy: When and why does democratization promote energy transition?

Autor: Clulow, Z., Reiner, D.

Despite the growing consensus surrounding the need to decarbonize power for meeting the ambitious temperature target set out in the 2015 Paris Agreement, the share of low-carbon energy sources in the overall energy mix varies significantly across cou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8cd29cb8f8dabd638337a90b8d9a3697

Communicating CCS: Effects of Text-only and Text-and-visual Depictions of CO2 Storage on Risk Perceptions and Attitudes

Autor: Brunsting, S., de Best-Waldhober, M., Brouwer, A.S., Riesch, H., Reiner, D.

Publikováno v: In Energy Procedia 2013 37:7318-7326

The case of 100% electrification of domestic heat in Great Britain

Autor: Charitopoulos, V., Fajardy, M., Chyong, C. K., Reiner, D.

Unlike power sector decarbonisation, there has been little progress made on heat, which is currently the biggest energy consumer in the UK, accounting for 45% of total energy consumption in 2019, and almost 40% of UK GHG emissions. Given the UK��

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34f9a460cceb713b8a696ce6c2f436b3